Fact CheckerSign in

NCT07142772Not yet recruiting

Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk

EMeRiT: Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk

Source: ClinicalTrials.gov · Last updated 27 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study will show the value of early genetic diagnosis in the case of MEG in a child and may lead to recommendations aimed at preventing tumor risk based on a simple and easily accessible clinical criterion (the measurement of head circumference). Ultimately, this study may improve cancer prognosis in the population of children with MEG.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
23 Apr 2025
Start date
Sept 2025
Primary completion date
Sept 2027
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT07142772

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From Sept 2025 to the primary completion date, Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have previously undergone genetic testing as part of their MEG, with or without a diagnosis
  • Patients who have not received the standard-of-care genetic analysis, specifically whole genome sequencing

Other

  • Patients with an etiological diagnosis of its MEG

Who the study is looking for

  • Patients with macrocephaly ≥ +3 DS due to brain MRI-confirmed MEG with or without NDD
  • Patient with a proposal to investigate a genetic etiology by genome sequencing
  • No objection by the patient's parents or guardians
  • Patients affiliated to a social security scheme

Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
service Génétique clinique Pitié-Salpêtrière / Trousseau
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.